Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05400252 · ClinicalTrials.gov registry record · NA

Whole Health in VA Mental Health: Omnis Salutis

A NA study of Anxiety Disorders and Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
238
Enrollment target
3
Study locations

NCT05400252: Recruiting NA study of Anxiety Disorders and Stress Disorders, Post-Traumatic, sponsored by VA Office of Research and Development.

NCT05400252 is a NA study of Anxiety Disorders and Stress Disorders, Post-Traumatic that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 238 participants, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05400252, a NA study of Anxiety Disorders and Stress Disorders, Post-Traumatic, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
238 participants
Enrollment target
3
Study locations

Study Summary

Recent Veterans of the Afghanistan and Iraq conflicts are presenting in VA care with high rates of posttraumatic stress disorder (PTSD), depression, anxiety, and substance use disorders. Difficulties with social relationships and community reintegration are common functional impairments with these disorders. VA is transforming to a Whole Health, patient-centered system of care that will address these issues as part of health care. In a previous study, Omnis Salutis (OS) was developed with Veteran and clinician input. OS is a three-session intervention in which Veterans learn about Whole Health and practice communicating their health mission to providers and social supports. OS was shown feasible to deliver, acceptable to Veterans, and preliminarily effective at improving physical, mental, and social functioning. This study will use a large, multisite randomized controlled trial to test the impact of OS on Veterans' social and physical functioning and Veteran engagement in mental health care. Results will support broad delivery of OS throughout the VA.

Primary Outcome

overall physical functioning; Item response scales differ but are scored on a 3-, 5-, or 6-point scale (possible range 0-64). Item responses are summed with higher scores indicating better functioning.

Interventions

  • BEHAVIORAL Omnis Salutis
  • BEHAVIORAL Health and Wellness

Study Locations (3)

Maryland

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Colorado

  • Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora

Trial Details

FieldValue
Enrollment Target 238 participants
Start Date 2023-02-01
Est. Completion 2026-10-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05400252 shows while recruiting

NCT05400252 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% lower).

The record links to 4 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Omnis Salutis is the first listed.

NCT05400252 reports a single indexed study location in Maryland, Colorado.

Frequently Asked Questions

What is clinical trial NCT05400252 about?

NCT05400252 is a clinical study titled "Whole Health in VA Mental Health: Omnis Salutis". Recent Veterans of the Afghanistan and Iraq conflicts are presenting in VA care with high rates of posttraumatic stress disorder (PTSD), depression, anxiety, and substance use disorders. Difficulties with social relationships and community reintegration are common functional impairments with these d...

What is the current status of trial NCT05400252?

This trial is currently recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2023-02-01. Estimated completion is 2026-10-31.

What conditions does trial NCT05400252 study?

This clinical trial studies the following conditions: Anxiety Disorders, Stress Disorders, Post-Traumatic, Substance-Related Disorders, Depressive Disorder.

What interventions are being tested in trial NCT05400252?

The interventions under investigation include: Omnis Salutis (BEHAVIORAL), Health and Wellness (BEHAVIORAL).

Who is sponsoring clinical trial NCT05400252?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05400252 being conducted?

This trial has 3 study locations across Colorado, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05400252's enrollment target sits among peer trials

238 22nd of 84 higher than 63 of 84 other Anxiety Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05012072 · 238 participants · NA

    Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

  • NCT06380517 · 238 participants · Phase 3

    Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

  • NCT06452797 · 238 participants · NA

    Prognostic Estimates Among ICU Clinicians

  • NCT06460012 · 238 participants · NA

    Support Via Technology: Living and Learning With Advancing Dementia-REVISED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05400252, the US trial registry maintained by the National Library of Medicine. NCT05400252 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.